|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 14475 |
FusionGeneSummary for GBA2_ATP6V1C1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: GBA2_ATP6V1C1 | Fusion gene ID: 14475 | Hgene | Tgene | Gene symbol | GBA2 | ATP6V1C1 | Gene ID | 57704 | 528 |
| Gene name | glucosylceramidase beta 2 | ATPase H+ transporting V1 subunit C1 | |
| Synonyms | AD035|NLGase|SPG46 | ATP6C|ATP6D|VATC|Vma5 | |
| Cytomap | 9p13.3 | 8q22.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | non-lysosomal glucosylceramidasebeta-glucocerebrosidase 2glucosidase, beta (bile acid) 2glucosylceramidase 2 | V-type proton ATPase subunit C 1ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1H(+)-transporting two-sector ATPase, subunit CH+ -ATPase C subunitH+-transporting ATPase chain C, vacuolarV-ATPase C subunitV-ATPase subunit C 1subunit C of vacu | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | Q9HCG7 | P21283 | |
| Ensembl transtripts involved in fusion gene | ENST00000378103, ENST00000378088, ENST00000378094, ENST00000545786, ENST00000467252, | ENST00000518857, ENST00000395862, ENST00000521514, ENST00000518738, | |
| Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 3 X 4 X 3=36 |
| # samples | 1 | 5 | |
| ** MAII score | log2(1/1*10)=3.32192809488736 | log2(5/36*10)=0.473931188332412 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: GBA2 [Title/Abstract] AND ATP6V1C1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | GBA2 | GO:0008206 | bile acid metabolic process | 17105727 |
| Hgene | GBA2 | GO:0016139 | glycoside catabolic process | 17105727 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | BRCA | TCGA-C8-A12U-01A | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000378103 | ENST00000518857 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| 5CDS-5UTR | ENST00000378103 | ENST00000395862 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| 5CDS-5UTR | ENST00000378103 | ENST00000521514 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| 5CDS-5UTR | ENST00000378103 | ENST00000518738 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| intron-5UTR | ENST00000378088 | ENST00000518857 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| intron-5UTR | ENST00000378088 | ENST00000395862 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| intron-5UTR | ENST00000378088 | ENST00000521514 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| intron-5UTR | ENST00000378088 | ENST00000518738 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| 5CDS-5UTR | ENST00000378094 | ENST00000518857 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| 5CDS-5UTR | ENST00000378094 | ENST00000395862 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| 5CDS-5UTR | ENST00000378094 | ENST00000521514 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| 5CDS-5UTR | ENST00000378094 | ENST00000518738 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| 5CDS-5UTR | ENST00000545786 | ENST00000518857 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| 5CDS-5UTR | ENST00000545786 | ENST00000395862 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| 5CDS-5UTR | ENST00000545786 | ENST00000521514 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| 5CDS-5UTR | ENST00000545786 | ENST00000518738 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| intron-5UTR | ENST00000467252 | ENST00000518857 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| intron-5UTR | ENST00000467252 | ENST00000395862 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| intron-5UTR | ENST00000467252 | ENST00000521514 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
| intron-5UTR | ENST00000467252 | ENST00000518738 | GBA2 | chr9 | 35748343 | - | ATP6V1C1 | chr8 | 104061098 | + |
Top |
FusionProtFeatures for GBA2_ATP6V1C1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| GBA2 | ATP6V1C1 |
| Non-lysosomal glucosylceramidase that catalyzes theconversion of glucosylceramide (GlcCer) to free glucose andceramide. Involved in sphingomyelin generation and prevention ofglycolipid accumulation. May also catalyze the hydrolysis of bileacid 3-O-glucosides, however, the relevance of such activity isunclear in vivo. Plays a role in central nevous systemdevelopment. Required for proper formation of motor neuron axons.{ECO:0000269|PubMed:17105727, ECO:0000269|PubMed:23332916}. | Subunit of the peripheral V1 complex of vacuolar ATPase.Subunit C is necessary for the assembly of the catalytic sector ofthe enzyme and is likely to have a specific function in itscatalytic activity. V-ATPase is responsible for acidifying avariety of intracellular compartments in eukaryotic cells. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for GBA2_ATP6V1C1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for GBA2_ATP6V1C1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| GBA2 | APP, TMEM216, SRP68, PPFIA1, BAG5, LAMTOR5, AFG3L2, ILVBL, MRPS22, MRPL44, MTNR1A | ATP6V1C1 | ATP6V1B1, ATP6V1E1, VASP, MOV10, SRSF5, ABCD3, CISD1, TYMS, ATP6AP1, MGST3, CPT1A, SSR1, TXNDC17, MRPS35, UBAC2, ANP32E, ARFIP1, ATG7, TBC1D15, VTA1, CTTN, DNM1L, GSPT1, GSPT2, GTF2A1, IDE, IVNS1ABP, LUC7L2, NASP, PAWR, PSMG3, RDX, SARS, SHMT1, SHMT2, SNX1, SNX2, SNX6, STAT1, TSN, VPS29, VPS35, ATP6V1C1, CDCA3, ATP6AP2, ATP6V1C2, ATL3, ALDH3A2, HDDC3, LAMTOR5, NDUFA9, PHB2, RAB14, SEC31A, PPP2R1A, SMS, ATP6V0A2, TLDC2, DNAAF2, DGUOK, NUFIP1 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for GBA2_ATP6V1C1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for GBA2_ATP6V1C1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | GBA2 | C2828721 | SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE | 2 | ORPHANET;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|